In a regulatory filing, Vera Therapeutics (VERA) disclosed that its Patrick Enright bought 5.9K shares of common stock on December 11th in a total transaction size of $250K.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERA:
- Vera Therapeutics price target raised to $33 from $23 at Wedbush
- Vera Therapeutics Completes Successful Stock Offering
- Vera Therapeutics 6.14M share Secondary priced at $42.50
- Vera Therapeutics offers to sell up to $200M in common stock
- Vera Therapeutics price target raised to $97 from $75 at Evercore ISI